Contraline, a clinical-stage biotechnology company developing novel male contraceptives, has exercised its option to exclusively license the Nestorone®/Testosterone (NES/T) gel from the Population Council.
A joint report on the socio-economic vulnerabilities of street-connected boys in Dhaka city, Bangladesh compiled by the Population Council, Freedom Fund, and INCIDIN Bangladesh.